go-v.orgcodex
Menu
Page tools

codex · Chemistry

Evenamide

Evenamide (INNTooltip International Nonproprietary Name; developmental codes NW-3509 and NW-3509A) is a selective voltage-gated sodium channel blocker, including (and not limited to) subtypes Nav1.3, Nav1.7, and Nav1.8, which is described as an antipsychotic and is under development by Newron Pharmaceuticals as an add-on therapy for the treatment of schizophrenia. The drug has shown efficacy in animal models of psychosis, mania, depression, and aggression. The drug was discovered by Newron Pharmaceuticals SpA, a pharmaceutical company located in Italy. Enigma TRS -1 and -2 Phase 3 trials were announced in late 2025.

Wikipedia contributors, "Evenamide", Wikipedia, revision 1378030809, retrieved 20 November 2026, source, CC BY-SA 4.0.

More Chemistry · Search the codex